Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,099 | -543 | -1,079 | -699 | -525 |
| Depreciation Amortization | 287 | 149 | 668 | 514 | 351 |
| Accounts receivable | 395 | -10 | -422 | -68 | -115 |
| Accounts payable and accrued liabilities | -282 | -236 | 277 | -125 | 112 |
| Other Working Capital | 58 | -175 | -60 | -48 | 296 |
| Other Operating Activity | 163 | 325 | 733 | 600 | 309 |
| Operating Cash Flow | $-478 | $-490 | $116 | $173 | $428 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -18 | -18 | -18 |
| Other Investing Activity | -63 | -42 | -147 | -124 | -91 |
| Investing Cash Flow | $-63 | $-42 | $-165 | $-141 | $-109 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -2 | -16 | -11 | -11 |
| Common Stock Issued | N/A | N/A | 19 | N/A | N/A |
| Other Financing Activity | -150 | -150 | -160 | -495 | -330 |
| Financing Cash Flow | $-155 | $-152 | $-157 | $-506 | $-341 |
| Beginning Cash Position | 1,146 | 1,146 | 1,352 | 1,352 | 1,352 |
| End Cash Position | 451 | 463 | 1,146 | 877 | 1,329 |
| Net Cash Flow | $-695 | $-683 | $-206 | $-475 | $-23 |
| Free Cash Flow | |||||
| Operating Cash Flow | -478 | -490 | 116 | 173 | 428 |
| Capital Expenditure | 0 | N/A | -18 | -18 | -18 |
| Free Cash Flow | -478 | -490 | 98 | 156 | 410 |